The annual AusBiotech conference brings together Australian and international biotech leaders and stakeholders. For more than three decades, the event has created a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.
AusBiotech is dedicated to consolidating this growth, and our 2018 conference will once again present issues critical to industry. Global biotech trends, breakthroughs, challenges and success stories will feature prominently on the program. Panel discussions and key themes will cover regulation and reimbursement, research translational strategies, new markets, business development and capital access, emerging technologies, clinical trials and commercialisation.
The Millis Oration is named after Emertius Professor Nancy Millis (1922-2012), the First Lady of biotechnology.
Dr Carol Dahl, Chief of Staff, Global Health Program & Director, Global Health Technologies, Bill & Melinda Gates Foundation, USA
Dr Alan Trounson, President, California Institute for Regenerative Medicine, California USA
Dr Megan Clark, Chief Executive, CSIRO, Australia
Professor Nadia Rosenthal, Director, Australian Regenerative Medicine Institute, Monash University, Australia
Professor Ross McKinnon, Research Director and Professor in Cancer Research, Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Australia
Dr Alan Robertson, Chief Executive Officer, Pharmaxis, Australia
Dr Mark Shackleton Medical Oncologist & Group Leader, Melanoma Research Laboratory Peter MacCallum Cancer Centre, Australia
Professor Goran Roos Chair, Advanced Manufacturing Council, Australia
Professor Balram Bhargava Professor of Cardiology, All India Institute of Medical Sciences
Prof Frank Gannon Director & CEO, QIMR Berghofer Medical Research Institute, Australia
Professor Carola Vinuesa, Head, Department of Pathogens and Immunity, Australian National University College of Medicine, Biology and Environment
Prof Ian Gust, Professorial Fellow, University of Melbourne, Australia
Dr Glenn Begley, CEO, BioCurate Pty Ltd, Australia
Professor Doug Hilton, Institute Director, Division Head of molecular Medicine, Walter & Eliza Hall Institute, Australia
One day investment event bringing world-leading biotech innovators together with Australia's early stage investment community to fund the future of life sciences. Featuring a mix of expert keynotes and life sciences company presentations, the event merges market intelligence with investment opportunities and will encourage successful biotech investment.
We gratefully acknowledge our session partners: